[go: up one dir, main page]

CY635A - Attenuated live rubella virus vaccine and method of production - Google Patents

Attenuated live rubella virus vaccine and method of production

Info

Publication number
CY635A
CY635A CY63572A CY63572A CY635A CY 635 A CY635 A CY 635A CY 63572 A CY63572 A CY 63572A CY 63572 A CY63572 A CY 63572A CY 635 A CY635 A CY 635A
Authority
CY
Cyprus
Prior art keywords
production
virus vaccine
rubella virus
attenuated live
live rubella
Prior art date
Application number
CY63572A
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10444820&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY635(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of CY635A publication Critical patent/CY635A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/20Rubella virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36211Rubivirus, e.g. rubella virus
    • C12N2770/36234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY63572A 1966-10-21 1972-03-07 Attenuated live rubella virus vaccine and method of production CY635A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47399/66A GB1135987A (en) 1966-10-21 1966-10-21 Attenuated live rubella virus vaccine and method of production

Publications (1)

Publication Number Publication Date
CY635A true CY635A (en) 1972-03-07

Family

ID=10444820

Family Applications (1)

Application Number Title Priority Date Filing Date
CY63572A CY635A (en) 1966-10-21 1972-03-07 Attenuated live rubella virus vaccine and method of production

Country Status (19)

Country Link
US (1) US3686394A (en)
AT (1) AT279038B (en)
BE (1) BE705342A (en)
BR (1) BR6794003D0 (en)
CA (1) CA956232A (en)
CH (1) CH477553A (en)
CY (1) CY635A (en)
DE (1) DE1617775B1 (en)
DK (1) DK121619B (en)
ES (1) ES345972A1 (en)
FI (1) FI43625B (en)
FR (2) FR1548489A (en)
GB (1) GB1135987A (en)
IL (1) IL28696A (en)
LU (1) LU54664A1 (en)
NL (1) NL148799B (en)
NO (1) NO125776B (en)
SE (1) SE341451B (en)
YU (1) YU31804B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129777C3 (en) * 1971-06-16 1982-04-15 Takeda Chemical Industries, Ltd., Osaka Process for the preparation of a severely weakened rubella virus vaccine
FR2505657A1 (en) * 1981-05-13 1982-11-19 Pasteur Institut IMPROVEMENTS IN LIVE STABILIZING AGENTS FOR THE PREPARATION OF VACCINES, AND STABILIZED VACCINES CONTAINING SAID STABILIZING AGENTS
US8460680B2 (en) * 2009-04-24 2013-06-11 National Health Research Institutes Polyvalent chimeric rubella virus-based vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401084A (en) * 1965-07-29 1968-09-10 Merck & Co Inc Rubella vaccine and its preparation

Also Published As

Publication number Publication date
CH477553A (en) 1969-08-31
IL28696A (en) 1971-12-29
NO125776B (en) 1972-10-30
BE705342A (en) 1968-03-01
FI43625B (en) 1971-02-01
FR7321M (en) 1969-10-06
BR6794003D0 (en) 1973-02-22
NL148799B (en) 1976-03-15
US3686394A (en) 1972-08-22
YU203467A (en) 1973-06-30
GB1135987A (en) 1968-12-11
CA956232A (en) 1974-10-15
NL6714223A (en) 1968-04-22
DK121619B (en) 1971-11-08
FR1548489A (en) 1968-12-06
ES345972A1 (en) 1968-12-01
AT279038B (en) 1970-02-25
DE1617775B1 (en) 1970-10-22
YU31804B (en) 1973-12-31
LU54664A1 (en) 1967-12-12
SE341451B (en) 1971-12-27

Similar Documents

Publication Publication Date Title
IL32382A0 (en) 7-halo-7-deoxy-lincomycin and method of preparation thereof
CA933863A (en) Attenuated live measles virus vaccine and method of production
CS191868B2 (en) Method of preparing live virus vaccine
IL27044A (en) 4-hydroxyquinoline 3-carboxylates and methods of preparing them
CY635A (en) Attenuated live rubella virus vaccine and method of production
IL27982A (en) Substituted salicylanilides and methods of preparing same
IL30168A0 (en) Antigen-free vaccine and process for preparing it
AU413666B2 (en) Attentuated live rubella virus vaccine and method of production
BR6676474D0 (en) ANTIGENIC PREPARATION AND VACCINE
AU2796167A (en) Attentuated live rubella virus vaccine and method of production
IL27424A (en) Method of preparing 5-benzylpyrimidines and novel 5-benzylpyrimidines
GB1187036A (en) Methods of and Plants for Burning Cement.
CA793277A (en) Attenuated live rabies vaccine and method of preparing the same
AU262929B2 (en) Attenuated live measles virus vaccine and method of production
IL31138A (en) Method of attenuating viruses
AU2393762A (en) Attenuated live measles virus vaccine and method of production
IL32962A0 (en) Method of preparing vaccine and product
AU264471B2 (en) Attenuated live rabies vaccine and method of preparing thesame
AU2539762A (en) Attenuated live rabies vaccine and method of preparing thesame
IL24948A (en) (alkylaminoethoxy)-dihaloanilines and method of preparation thereof
IL29985A0 (en) Benzene-sulphonamines and process of preparing them
CA862070A (en) Inactivated virus vaccine and process for producing same
CY536A (en) Vaccine and its preparation
CA725654A (en) Bis-trimellitimidoyl chlorides and method of preparation
AU407005B2 (en) Repository vaccine and method of preparing the same